Author:
Randazza Olivia,Erickson Kallie,Denmeade Travis,Luther Vera,Palavecino Elizabeth,Beardsley James
Reference11 articles.
1. Candida nivariensis: identification strategy in mycological laboratories;Cartier N;J Mycol Med,2020
2. First isolation of Candida nivariensis, an emerging fungal pathogen, in Kuwait;Alobaid K;Med Princ Pract,2021
3. Identification and antifungal susceptibility profiles of Candida nivariensis and Candida bracarensis in a multi-center Chinese collection of yeasts;Hou X;Front Microbiol,2017
4. Isavuconazole: mechanism of action, clinical efficacy, and resistance;Ellsworth M;J Fungi (Basel),2020
5. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species;Guinea J;Antimicrob Agents Chemother,2008